Podcast discusses sustaining workplace culture change
Two leaders discuss protecting institutional reforms during periods of organizational transition. The episode focuses on maintaining progress in misconduct prevention efforts.
rnz.co.nzA podcast episode examines the challenges of maintaining institutional reforms after initial implementation. The discussion centers on protecting changes when surrounding systems and personnel are also shifting.
Post by @WHO on X
Episode participants Two individuals address these issues in the recording.
One previously established foundational approaches to misconduct prevention. The other currently oversees related departmental operations and ongoing implementation. The conversation addresses expectations for the organization, participating governments, and stakeholders involved in sustaining these efforts.
Production details The episode runs 33 minutes and 48 seconds.
It was produced by the unit responsible for misconduct prevention and response activities. Additional resources include organizational materials on misconduct prevention and links to other episodes in the series.
Key Facts
Potential Impact
- 01
Listeners may gain information about maintaining institutional reforms during transitions.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…